-+ 0.00%
-+ 0.00%
-+ 0.00%

RHYTHM PHARMACEUTICALS ANNOUNCES PRELIMINARY DATA FROM PHASE 2 TRIAL THAT SHOWED RM-718 DEMONSTRATED POSITIVE EFFICACY SIGNAL IN ACQUIRED HYPOTHALAMIC OBESITY

路透·08/04/2026 10:55:00

登录查看新闻详情